Yoga for Patients With Irritable Bowel Syndrome

Randomized Controlled Trial on Yoga for Irritable Bowel Syndrome

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02721836

Enrollment

Registered

2016-03-29

Start date

2016-04-30

Completion date

2017-05-31

Last updated

2017-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Brief summary

The proposed study aims to investigate the feasibility, effectiveness, and perceived benefit of a hatha yoga intervention for patients with irritable bowel syndrome (IBS) compared to nutrition counselling. Further, the potential of both interventions to influence the gut microbiome will be inquired.

Interventions

BEHAVIORALYoga

Yoga intervention 12 weeks, twice weekly 75-minute intervention Yoga postures, breathing, relaxation, and meditation

BEHAVIORALNutrition Counselling

Evidence-based Nutrition Counselling, 3 appointments within 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Patients with irritable bowel syndrome (IBS) diagnosed by physician and confirmed by Rome III diagnostic criteria

Exclusion criteria

* inflammatory bowel diseases (IBD) * total abdominal colectomy * no sonographie or colonoscopy as diagnostic criterion * stool lactoferrin \> 7mg/g * pregnancy or breast feeding * simultaneous participation in further clinical intervention trials * Regular yoga practice or nutrition counselling in the past 12 months * Planned surgery in the study period * Serious illness that would interfere with the ability to practice yoga

Design outcomes

Primary

Measure	Time frame	Description
Irritable Bowel Syndrome Symptoms	Week 12	Irritable Bowel Syndrome Severity Scoring System (IBS-SSS)

Secondary

Measure	Time frame	Description
Generic Health-related Quality of life	Week 12	Short Form 36 Health Survey Questionnaire, SF-36
Emotional distress	Week 12	Hospital Anxiety and Depression Scale (HADS)
Subjective Stress	Week 12	Cohen Perceived Stress Scale (CPSS)
disease specific quality of life	Week 12	Irritable Bowel Syndrome Quality of Life measurement (IBS-QOL)
Gut microbiome	Week 12	Stool samples
Adverse Event	Week 12	—
Irritable Bowel Syndrome Symptoms	Week 24	Irritable Bowel Syndrome Severity Scoring System (IBS-SSS)
Subjective improvement of symptoms	Week 12	Adequate Relief Score and Global Improvement Scale (GI)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026